A commentary on "The efficacy and safety of probiotics in patients with irritable bowel syndrome: Evidence based on 35 randomized controlled trials" (Int J Surg 2020; 75:116-127)

Int J Surg. 2020 Apr:76:70. doi: 10.1016/j.ijsu.2020.02.019. Epub 2020 Feb 24.
No abstract available

Keywords: Commentary; Meta-analysis; Randomized control trials.

Publication types

  • Letter
  • Comment

MeSH terms

  • Abdominal Pain
  • Humans
  • Irritable Bowel Syndrome*
  • Probiotics*
  • Randomized Controlled Trials as Topic